phenobarbital and flumequine

phenobarbital has been researched along with flumequine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caron, G; Ermondi, G1
Ando, J; Kudoh, K; Maekawa, A; Miyajima, K; Nakae, D; Shiraki, K; Takahashi, M; Yoshida, M1
Kashida, Y; Mitsumori, K; Ohsawa, K; Sasaki, YF; Takahashi, A; Watanabe, T; Yokohama, N1
Ishii, Y; Jin, M; Kijima, A; Kodama, Y; Kuroda, K; Matsushita, K; Takasu, S; Umemura, T1

Other Studies

4 other study(ies) available for phenobarbital and flumequine

ArticleYear
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
    Journal of medicinal chemistry, 2005, May-05, Volume: 48, Issue:9

    Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water

2005
Hepatotoxicity and consequently increased cell proliferation are associated with flumequine hepatocarcinogenesis in mice.
    Cancer letters, 1999, Jul-01, Volume: 141, Issue:1-2

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adenoma; Animals; Anti-Infective Agents; Carcinogenicity Tests; Cell Division; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP2B1; Cytochrome P-450 Enzyme System; Deoxyguanosine; Diethylnitrosamine; Fluoroquinolones; Immunohistochemistry; Liver; Liver Neoplasms; Male; Mice; Phenobarbital; Proliferating Cell Nuclear Antigen; Quinolizines; Steroid Hydroxylases

1999
Mechanistic study on flumequine hepatocarcinogenicity focusing on DNA damage in mice.
    Toxicological sciences : an official journal of the Society of Toxicology, 2002, Volume: 69, Issue:2

    Topics: Animals; Anti-Infective Agents; Carcinogenicity Tests; Carcinogens; Cell Line; Cell Nucleus; Comet Assay; DNA Damage; Fluoroquinolones; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C3H; Phenobarbital; Quinolizines; Topoisomerase II Inhibitors

2002
Flumequine enhances the in vivo mutagenicity of MeIQx in the mouse liver.
    Archives of toxicology, 2013, Volume: 87, Issue:8

    Topics: Animals; Body Weight; Cell Proliferation; Cyclin D1; Cytochrome P-450 CYP1A2; Drug Synergism; Fluoroquinolones; Glucuronosyltransferase; Hepatocytes; Liver; Male; Mice; Mice, Transgenic; Mutagens; Mutation; Oligonucleotide Array Sequence Analysis; Phenobarbital; Quinoxalines

2013